{{Drugbox
| Verifiedfields = 
| Watchedfields = 
| verifiedrevid = 
| IUPAC_name = Heptan-2-amine<ref>{{Cite web|title=
tuamine - Compound Summary|url=https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=5603&loc=ec_rcs#x291|publisher=National Center for Biotechnology Information|accessdate=31 May 2012|location=USA|date=25 March 2005|at=Identification and Related Records}}</ref>
| image = Tuaminoheptane.png
| width = 225px

<!--Clinical data-->
| tradename = Heptin, Heptadrine, Tuamine
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration = 

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion = 

<!-- Identifiers -->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 123-82-0
| CAS_supplemental = <br />6240-90-0 ((''R'')-isomer)<br />44745-29-1 ((''S'')-isomer)
| class = 
| ATC_prefix = R01
| ATC_suffix = AA11
| ATC_supplemental = <br />{{ATC|R01|AB08}} (combinations)
| PubChem = 5603
| IUPHAR_ligand = 
| DrugBank_Ref = 
| DrugBank = 
| ChemSpiderID_Ref = 
| ChemSpiderID = 5401
| UNII = Z0420GYD84
| UNII_Ref = {{fdacite|correct|FDA}}
| KEGG = D07371
| KEGG_Ref = {{keggcite|correct|kegg}}
| ChEBI = 
| ChEMBL = 123693
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| synonyms = Tuamine; 2-Aminoheptane; 2-Heptanamine; 1-Methylhexylamine

<!--Chemical data-->
| C=7 | H=17 | N=1
| molecular_weight = 
| SMILES = CCCCCC(C)N
| StdInChI = 1S/C7H17N/c1-3-4-5-6-7(2)8/h7H,3-6,8H2,1-2H3
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = VSRBKQFNFZQRBM-UHFFFAOYSA-N
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| density = 0.766 g/mL
}}

'''Tuaminoheptane''' ({{abbrlink|INN|International Nonproprietary Name}}, {{abbrlink|BAN|British Approved Name}}) (brand names '''Heptin''', '''Heptadrine''', '''Tuamine'''), or simply '''tuamine''', also known as '''2-aminoheptane''', is a [[sympathomimetic agent]] and [[vasoconstrictor]] which was formerly used as a [[nasal decongestant]].<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA623|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=623–}}</ref><ref name="MortonHall2012">{{cite book|author1=I.K. Morton|author2=Judith M. Hall|title=Concise Dictionary of Pharmacological Agents: Properties and Synonyms|url=https://books.google.com/books?id=tsjrCAAAQBAJ&pg=PA282|date=6 December 2012|publisher=Springer Science & Business Media|isbn=978-94-011-4439-1|pages=282–}}</ref><ref name="pmid13591086">{{cite journal | vauthors = NICKERSON M, DRESEL PE | title = Adrenergic drugs and their antagonists | journal = Postgrad Med | volume = 24 | issue = 3 | pages = 246–56 | year = 1958 | pmid = 13591086 | doi = | url = }}</ref> It has also been used as a [[stimulant]].<ref name="pmid18500382" /><ref name="pmid20122452">{{cite journal | vauthors = Thevis M, Sigmund G, Geyer H, Schänzer W | title = Stimulants and doping in sport | journal = Endocrinol. Metab. Clin. North Am. | volume = 39 | issue = 1 | pages = 89–105, ix | year = 2010 | pmid = 20122452 | doi = 10.1016/j.ecl.2009.10.011 | url = }}</ref>

Tuaminoheptane has been found to act as a [[reuptake inhibitor]] and [[releasing agent]] of [[norepinephrine]], which may underlie its decongestant and stimulant effects.<ref name="pmid2386550">{{cite journal | vauthors = Delicado EG, Fideu MD, Miras-Portugal MT, Pourrias B, Aunis D | title = Effect of tuamine, heptaminol and two analogues on uptake and release of catecholamines in cultured chromaffin cells | journal = Biochem. Pharmacol. | volume = 40 | issue = 4 | pages = 821–5 | year = 1990 | pmid = 2386550 | doi = | url = }}</ref><ref name="pmid21885739">{{cite journal | vauthors = Schlessinger A, Geier E, Fan H, Irwin JJ, Shoichet BK, Giacomini KM, Sali A | title = Structure-based discovery of prescription drugs that interact with the norepinephrine transporter, NET | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 108 | issue = 38 | pages = 15810–5 | year = 2011 | pmid = 21885739 | pmc = 3179104 | doi = 10.1073/pnas.1106030108 | url = }}</ref><ref name="pmid20122452" /> It is an [[Amine#Classes of amines|alkylamine]].<ref name="pmid20122452" /> The [[chemical structure]] of the drug differs from that of other [[norepinephrine releasing agent]]s, such as the [[substituted phenethylamine|phenethylamine]]s, which, in contrast to tuaminoheptane, have an [[aromatic ring]] in their structure.<ref name="pmid21885739" /> Tuaminoheptane is also a [[skin irritant]] and can cause [[contact dermatitis]] via [[channel blocker|inhibition]] of [[volume-regulated anion channel]]s, which limits its usefulness as a decongestant.<ref name="pmid17384225">{{cite journal | vauthors = Raoux M, Colomban C, Delmas P, Crest M | title = The amine-containing cutaneous irritant heptylamine inhibits the volume-regulated anion channel and mobilizes intracellular calcium in normal human epidermal keratinocytes | journal = Mol. Pharmacol. | volume = 71 | issue = 6 | pages = 1685–94 | year = 2007 | pmid = 17384225 | doi = 10.1124/mol.106.033324 | url = }}</ref>

Tuaminoheptane is on the 2011 list of prohibited substances published by the [[World Anti-Doping Agency]].<ref name="pmid18500382">{{cite journal | vauthors = Docherty JR | title = Pharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA) | journal = Br. J. Pharmacol. | volume = 154 | issue = 3 | pages = 606–22 | year = 2008 | pmid = 18500382 | pmc = 2439527 | doi = 10.1038/bjp.2008.124 | url = }}</ref>

==See also==
* [[1,3-Dimethylbutylamine]]
* [[Heptaminol]]
* [[Isometheptene]]
* [[Methylhexanamine]]
* [[Octodrine]]

==References==
{{Reflist|2}}

==External links==
* [http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited-list/To_be_effective/WADA_Prohibited_List_2011_EN.pdf The World Anti-Doping Code. The 2011 Prohibited List. International Standard]

{{Nasal preparations}}
{{Stimulants}}
{{Monoamine releasing agents}}

[[Category:Abandoned drugs]]
[[Category:Amines]]
[[Category:Decongestants]]
[[Category:Ion channel blockers]]
[[Category:Norepinephrine releasing agents]]
[[Category:Stimulants]]